o NoneEntity Type
0001348362
LEXARIA CORP.
Lexaria Corp.
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 Lexaria Bioscience Corp.
Jurisdiction of Incorporation/OrganizationNEVADA 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 Lexaria Bioscience Corp. 
Street Address 1Street Address 2
 100 - 740 MCCURDY ROAD 
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 KELOWNA BRITISH COLUMBIA, CANADA V1X 2P7 250-765-6424 



3. Related Persons
Last NameFirst NameMiddle Name
BUNKACHRISTOPHER
Street Address 1Street Address 2
100 - 740 MCCURDY ROAD
CityState/Province/CountryZIP/Postal Code
KELOWNABRITISH COLUMBIA, CANADAV1X 2P7
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
DochertyJohn
Street Address 1Street Address 2
100 - 740 MCCURDY ROAD
CityState/Province/CountryZIP/Postal Code
KELOWNABRITISH COLUMBIA, CANADAV1X 2P7
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
SpissingerAllan
Street Address 1Street Address 2
100 - 740 MCCURDY ROAD
CityState/Province/CountryZIP/Postal Code
KELOWNABRITISH COLUMBIA, CANADAV1X 2P7
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
BaxterNicholas
Street Address 1Street Address 2
100 - 740 MCCURDY ROAD
CityState/Province/CountryZIP/Postal Code
KELOWNABRITISH COLUMBIA, CANADAV1X 2P7
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 
Last NameFirst NameMiddle Name
McKechnieTed
Street Address 1Street Address 2
100 - 740 MCCURDY ROAD
CityState/Province/CountryZIP/Postal Code
KELOWNABRITISH COLUMBIA, CANADAV1X 2P7
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
QuigleyBrian
Street Address 1Street Address 2
100 - 740 MCCURDY ROAD
CityState/Province/CountryZIP/Postal Code
KELOWNABRITISH COLUMBIA, CANADAV1X 2P7
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  o Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance x Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2020-05-06 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
x Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
 Bradley Woods & Co. Ltd. 13660
(Associated) Broker or Dealer x None(Associated) Broker or Dealer CRD Number x None
    
Street Address 1Street Address 2
 805 Third Avenue, 18th Fl  
City State/Province/CountryZIP/Postal Code
 New York NEW YORK 10022
State(s) of Solicitation o All States x Foreign/Non-US
 CALIFORNIA
 CONNECTICUT
 ILLINOIS
 NEW YORK
 PENNSYLVANIA
 WISCONSIN
 

 



13. Offering and Sales Amounts
Total Offering Amount $ 2039228 USD o Indefinite
Total Amount Sold $ 2039228 USD 
Total Remaining to be Sold $ 0 USD o Indefinite
 
Clarification of Response (if Necessary)
  


14. Investors
x Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
1
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 21


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 151623 USD o Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
 In addition to the sales commission,the Company issued to the placement agent and its designees Warrants to purchase up to 649,123 shares of common stock and shall, subject to certain exceptions, pay 8% of the proceeds received from warrant exercises.


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o
Lexaria Bioscience (QX) (USOTC:LXRP)
Historical Stock Chart
From Apr 2020 to May 2020 Click Here for more Lexaria Bioscience (QX) Charts.
Lexaria Bioscience (QX) (USOTC:LXRP)
Historical Stock Chart
From May 2019 to May 2020 Click Here for more Lexaria Bioscience (QX) Charts.
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.